Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent van der Noort

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Molecular Oncology|June 8, 2022
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patientsDaan C L Vessies, Milou M F Schuurbiers, Vincent van der Noort, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 5, 2021
Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancerMirte Muller, Roland Hoogendoorn, Ruben J G Moritz, et al.
World Journal of Urology|October 16, 2022
External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohortMarinus J Hagens, Piter J Stelwagen, Hans Veerman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2023
A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile CarcinomaSarah Rosanne Ottenhof, Hielke Martijn de Vries, Barry Doodeman, et al.
European Urology|August 6, 2014
Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancerGijs H KleinJan, Nynke S van den Berg, Oscar R Brouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction TrialMichiel M Smeenk, Judi N A van Diessen, Thierry N Boellaard, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2018
Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural MesotheliomaJosine Quispel-Janssen, Vincent van der Noort, Jeltje F de Vries, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Molecular Oncology|June 8, 2022
Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patientsDaan C L Vessies, Milou M F Schuurbiers, Vincent van der Noort, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 5, 2021
Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancerMirte Muller, Roland Hoogendoorn, Ruben J G Moritz, et al.
World Journal of Urology|October 16, 2022
External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohortMarinus J Hagens, Piter J Stelwagen, Hans Veerman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2023
A Prospective Study of Chemoradiotherapy as Primary Treatment in Patients With Locoregionally Advanced Penile CarcinomaSarah Rosanne Ottenhof, Hielke Martijn de Vries, Barry Doodeman, et al.
European Urology|August 6, 2014
Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancerGijs H KleinJan, Nynke S van den Berg, Oscar R Brouwer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction TrialMichiel M Smeenk, Judi N A van Diessen, Thierry N Boellaard, et al.
Pageof 11